Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Dr. Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Hacettepe University Faculty of Medicine, Department of Pediatric Immunology and Allergy at Hacettepe University Faculty of Medicine, Turkey

Dr. Hilal Ünsal is a distinguished pediatric allergist and clinical immunologist specializing in the diagnosis and management of allergies and immunodeficiencies in children. With extensive training and clinical experience, Dr. Ünsal has become a prominent figure in the field of pediatric allergy, contributing significantly to both clinical practice and research. Currently pursuing advanced studies in Pediatric Allergy and Clinical Immunology at Hacettepe University, she combines her clinical expertise with a strong research background, particularly in primary immunodeficiencies, food allergies, and asthma. Her work has been published in several reputable journals, and she is an active participant in international conferences, reflecting her commitment to advancing medical knowledge and improving patient outcomes.

Professional Profile

Education

Dr. Ünsal earned her Medical Degree from Gazi University, Faculty of Medicine in 2012, where she graduated as an honor student. She then pursued a residency in pediatrics at Health Sciences University Dr. Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital, completing her training in 2018. Currently, she is completing a Clinical Fellowship in Pediatric Allergy and Clinical Immunology at Hacettepe University, a program that is enhancing her expertise in the immunologic aspects of pediatric diseases. Dr. Ünsal’s academic path reflects her dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Ünsal’s professional journey has been centered on pediatric allergy and immunology. After completing her medical education and residency, she further honed her skills in pediatric immunology during her fellowship at Hacettepe University, one of Turkey’s leading medical institutions. Over the years, Dr. Ünsal has actively contributed to the diagnosis and management of pediatric allergies, asthma, and immunodeficiencies, working in various clinical settings. Her experience spans the diagnosis of IgE-mediated food allergies, asthma exacerbations, and immunodeficiencies, as well as advanced research in these areas. She has gained a reputation for her meticulous approach to clinical research and patient care.

Research Interests

Dr. Ünsal’s research focuses on the intricate relationships between primary immunodeficiencies, genetics, and pediatric allergies. Her specific interests include food allergies, drug allergies, allergic rhinitis, and asthma, with a strong emphasis on understanding the genetic and immunological factors contributing to these conditions in children. She is particularly dedicated to identifying novel allergens and improving diagnostic methods for food allergies, as well as exploring the role of oxidative stress in asthma. Through her research, Dr. Ünsal aims to improve the quality of life for children suffering from these conditions by enhancing early diagnosis, treatment strategies, and prevention methods.

Research Skills

Dr. Ünsal has developed robust research skills, particularly in the areas of biostatistics, immunological testing, and clinical research methodologies. She is proficient in using SPSS for data analysis, enabling her to conduct rigorous statistical evaluations of her research data. Her research skills are further enhanced by her involvement in multiple projects on food allergies, asthma, and immunodeficiencies. Dr. Ünsal’s expertise in interpreting complex immunological data, along with her ability to work with diverse patient populations, has allowed her to contribute to significant studies in her field. Her active participation in both clinical and experimental research ensures that her work remains at the forefront of pediatric allergy and immunology.

Awards and Honors

Dr. Ünsal’s academic and research excellence has been recognized by her peers and academic institutions. As an honor student at Gazi University, she demonstrated early promise in her medical career. Her ongoing contributions to the field of pediatric allergy and immunology have earned her opportunities to present at numerous prestigious conferences, including the European Academy of Allergy and Clinical Immunology (EAACI) Congress and the World Allergy Congress. Additionally, her research has been published in well-regarded journals such as Pediatric Allergy and Immunology and Turkish Journal of Medical Sciences, which highlights her commitment to advancing knowledge in her field.

Conclusion

Dr. Hilal Ünsal is highly deserving of the Best Researcher Award based on her extensive body of work, leadership in research, and active participation in international conferences. Her expertise in pediatric immunology and allergy is well-documented, and her ongoing research in immunodeficiencies and food allergies is crucial for advancing clinical practice in these areas. While further strengthening her clinical impact and broadening her research funding could enhance her profile, her current contributions to the field place her as a prominent figure in her discipline. Dr. Ünsal is well-positioned for continued excellence in research, making her an excellent candidate for this prestigious award

Publication Top Notes

  1. Title: The treatment journey of children with moderate to severe atopic dermatitis in Türkiye: unmet needs
    • Authors: İlgün Gürel, D., Ünsal, H., Soyak Aytekin, E., Ersoy Evans, S., Şekerel, B.E.
    • Year: 2024
  2. Title: A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey
    • Authors: Ünsal, H., Caka, C., Bildik, H.N., Tezcan, İ., Çağdaş, D.
    • Year: 2024
    • Citations: 2
  3. Title: Cupressus arizonica: an emerging aeroallergen for East Mediterranean children
    • Authors: Ünsal, H., Şahiner, Ü.M., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
  4. Title: Phenotypes of persistent hen’s egg allergy in children and adolescents
    • Authors: Ünsal, H., Dal, S.T., Akarsu, A., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
    • Citations: 2
  5. Title: Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma
    • Authors: Soyak Aytekin, E., Sahiner, U.M., Tuten Dal, S., Sekerel, B.E., Soyer, O.
    • Year: 2022
    • Citations: 9
  6. Title: IgE mediated legume allergy in east Mediterranean children: A reflection of multiple food allergies
    • Authors: Soyak Aytekin, E., Unsal, H., Sahiner, U.M., Soyer, O., Sekerel, B.E.
    • Year: 2022
    • Citations: 4
  7. Title: Comparison of miRNA expression in patients with seasonal and perennial allergic rhinitis and non-atopic asthma
    • Authors: Tunçer, F., Şahiner, Ü.M., Ocak, M., Şekerel, B.E., Birben, E.
    • Year: 2022
    • Citations: 4
  8. Title: Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients
    • Authors: Sekerel, B.E., Unsal, H., Sahiner, U.M., Karakaya, G., Kalyoncu, A.F.
    • Year: 2022
    • Citations: 5
  9. Title: Food allergy management has been negatively impacted during the COVID-19 pandemic
    • Authors: Soyak Aytekin, E., Tüten Dal, S., Ünsal, H., Soyer, Ö., Şekerel, B.E.
    • Year: 2021
    • Citations: 2
  10. Title: Allergic reactions against COVID-19 vaccines
    • Authors: Ünsal, H., Şekerel, B.E., Şahiner, Ü.M.
    • Year: 2021
    • Citations: 4

 

Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain

Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine.

Profile

Education

Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences.

Professional Experience

Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology.

Research Interest

Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science.

Research Skills

Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care.

Award and Recognition

Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research.

Conclusion

Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award.

Publication Top Notes

  1. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study
    • Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F.
    • Year: 2024
    • Journal: HLA
  2. CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
    • Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M.
    • Year: 2023
    • Journal: Frontiers in Bioscience – Landmark
    • Citations: 1
  3. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
    • Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M.
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Citations: 5
  4. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
    • Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M.
    • Year: 2023
    • Journal: Frontiers in Immunology
    • Citations: 4
  5. Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor
    • Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F.
    • Year: 2022
    • Journal: HLA
    • Citations: 2
  6. The age again in the eye of the COVID-19 storm: evidence-based decision making
    • Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J.
    • Year: 2021
    • Journal: Immunity and Ageing
    • Citations: 7
  7. The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor
    • Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A.
    • Year: 2021
    • Journal: HLA
    • Citations: 2
  8. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome
    • Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M.
    • Year: 2021
    • Journal: Current Protein and Peptide Science
    • Citations: 2
  9. Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain
    • Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R.
    • Year: 2021
    • Journal: Human Immunology
    • Citations: 1
  10. Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study
    • Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M.
    • Year: 2021
    • Journal: Journal of Clinical Medicine
    • Citations: 14